Os Therapies Incorporated · AMEX:OSTX
Thomas A. Satterfield, Jr. reported a 9.40% stake in Os Therapies Incorporated (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 13, 2025
Thomas A. Satterfield, Jr. reported a 9.40% stake in Os Therapies Incorporated, 3,115,681 shares, as a passive investor on Jun 30, 2025. Filed Aug 13, 2025 (Schedule 13G/A).
- Stake
- 9.40%
- Shares
- 3,115,681
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Thomas A. Satterfield, Jr. | 9.40% | 3,115,681 |
Source
Related
- Os Therapies Incorporated
- Thomas A. Satterfield, Jr.
- Os Therapies Incorporated shareholders
- Schedule 13G/A · Thomas A. Satterfield, Jr. · Feb 12, 2025
- Schedule 13D/A · Shalom Auerbach · Aug 18, 2025
- Schedule 13D/A · Shalom Auerbach · May 9, 2025
- Schedule 13G · Ayala Pharmaceuticals, Inc. · Apr 16, 2025
- Schedule 13D/A · Shalom Auerbach · Mar 12, 2025
- Schedule 13D/A · Shalom Auerbach · Feb 28, 2025